Financial Management Network Inc Sarepta Therapeutics, Inc. Transaction History

Financial Management Network Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 19, 2022	SELL	$77.28 - $99.42 $203,632 - $261,971	-2,635 Closed	0 $0
Q3 2021 Oct 13, 2021	BUY	$65.97 - $92.48 $173,830 - $243,684	2,635 New	2,635 $249,000
Q2 2021 Jul 20, 2021	SELL	$69.38 - $86.75 $182,816 - $228,586	-2,635 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$72.25 - $168.95 $190,378 - $445,183	2,635 New	2,635 $203,000

529

84.1M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Financial Management Network Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Management Network Inc with notifications on news.